Even Convertible Arbitrageurs Are Abandoning China

Global investors are gobbling up bonds that can be turned into stocks, feeling good about the prospects and return potentials of smaller companies.

In the US, convertible bond issues have been at the highest since 2021, when near-zero interest rates during the pandemic fueled a boom. In Australia, mid-sized Telix Pharmaceuticals Ltd. found enough demand last week to upsize its offering to A$650 million ($422 million), in what would be the largest health-care equity-linked issue in Asia in three years. Meanwhile, the frenzy for artificial intelligence is making Taiwan a hotbed for convertibles.

But the enthusiasm doesn’t seem to extend to Chinese companies. After a brief rush of issues from tech giants in May, which gave investment bankers in Hong Kong some revenue and reprieve, this offshore convertible craze is already running out of steam. In hindsight, Ping An Insurance Group Co.’s $3.5 billion deal in mid-July is looking like the finale to a short-lived dream.

In mainland China, the situation goes far beyond a lack of new issuances. A $129 billion market, which has helped hundreds of smaller companies finance at cheaper costs, is facing an existential threat. About 21% of the 584 bonds outstanding are trading at below face value, the highest since the early pandemic days when businesses were shut down.

existential threat

Convertibles are a draw for hedge funds that try to capitalize on mispricing between hybrid products and the underlying stocks, as well as longer-term investors who want a bit more than just fixed income. At the same time, issuers are happy to enter the market. The interest rates they have to pay are a lot lower than on conventional debt, since they’re offering buyers the option of turning their debt into a company’s stock.